Franco-Italian Thales Alenia Space wins several contracts

The European Space Agency awards the first installments of two contracts to the Franco-Italian industrialist, for a total value of 600 million euros.

Artist's impression of the Lunar Gateway, the future space station orbiting the Moon.
Artist’s impression of the Lunar Gateway, the future space station orbiting the Moon. Thales Alenia Space

We’ll walk on the moon again. Better still, man will explore the Earth satellite from every angle, passing through the poles and its hidden face. The United States has decided, as part of the Artemis mission, to send four astronauts, including a woman, there in 2024.

Four years from this deadline, and despite the budgetary and technical obstacles, all the lights are green for the program. Piloted by NASA, Artemis would mark humanity’s return to the moon, fifty-five years after the successful Apollo 11 mission in July 1969, when Neil Armstrong and Buzz Aldrin were the first men to set foot on lunar soil.

Europe, via its space agency (ESA), is associated with this very tight schedule. Esa gets into the heart of the matter this Wednesday morning by notifying the first installments of two contracts with a cumulative value of nearly 600 million euros, to Thales Alenia Space (TAS), jointly owned by the defense group French Thales and Italian Leonardo.

This article is for subscribers only. You have 78% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time


“Musicians and medicine”, by Dr. Adolfo Martínez Palomo

MEXICO CITY ( .– When the bicentennial of Wolfang Amadeus Mozart’s death was commemorated in 1991, the Mexican doctor, scientist and academic Adolfo Martínez Palomo (1941) began the bibliographic search, writing and public presentation of the texts now published by El Colegio Nacional in fourteen double installments.

This new compact format series includes the biographies of: Monteverdi and Vivaldi, Bach and Handel, Haydn and Mozart, Beethoven and Paganini, Rossini and Schubert, Donizetti and Bellini, Berlioz and Mendelssohn, Chopin and Schumann, Liszt and Wagner, Verdi and Gounod , Clara Schumann and Brahms, Borodin and Bizet, Tchaikovski and Puccini, Mahler and Shostakovich.

Today we offer excerpts from the second volume entitled Musicians and medicine. Clinical histories of great composers. Bach and Handel (86 pages in 12 by 18 centimeter format, bibliography, illustrations and iconographic credits,, written by Martínez Palomo who has stood out for his research on the painful Herpes Zoster virus.

“Two colossi of classical music Johann Sebastian Bach (1685-1750) and Georg Frideric Handel (1685-1759), both born the same year in Germany and yet they did not manage to know each other personally. Bach always stays in his country, where he has twenty children. Handel, on the other hand, makes fame and fortune in England, without getting married. Long and prolific lives both, united with a common ending: blindness, caused by the clumsy intervention of the same apprentice eye surgeon. “

Creativity: inheritance or learning?

(…) With the forgiveness of fans of the hereditary theory of creativity, I would like to insist that nothing indicates in Johann Sebastian’s childhood or early adolescence the existence of a genius, rather, an exceptional effort to learn from their elders. (…)

At fifteen, our character eagerly copies compositions from others, at night, at an age when other musical geniuses have been writing music for a long time. At that age he has to leave his brother’s house, which is already insufficient due to the birth of four more nephews.

By the way, one of the physical attributes of Johann Sebastian that has caught the attention of his biographers has been… the strength of his legs! And is not for less. What a path he had to go in his youth to absorb the musical knowledge of the greats of his time! Nothing was too far away, nor was the weather so bad that it prevented him from making trips on foot in search of better knowledge. Thus, it traveled 40 km between Ohrdeuf and Eisenach and 360 km between Ohrdruf and Lüneburg. (…)

Bach, as we have said, had a foolproof health throughout his life, well into his period of maturity. A neurologist has commented, when analyzing the portrait of Bach, the obvious obesity of the composer and the presence of a slight facial paralysis, perhaps due to a cerebral infarction. If anything, the only well-documented physical weakness was his eye problem.

For ophthalmologists who have reviewed his history, Bach was probably nearsighted, judging by the appearance of the eyes in the only true portrait that survives, taken at age sixty-one [por Elias Gottlob Haussmann, en 1746, reproducido a colores en este libro de Martínez Palomo] which shows the composer “straining his eyes.” This myopia may have allowed him the hard work of reading and writing countless scores. (…)

On the advice of his friends, the composer consulted an English eye doctor, the gentleman John Taylor, who had operated, sometimes with some success, on many European personalities, including the contemporary Handel. Taylor was actually a great charlatan, dominating more of the art of advertising than of science (…)

In Bach’s time the usual medical treatment for cataracts ranged from esoteric diets, to bloodletting and the application of leeches. The surgical procedure was followed by washing the eyes with a mixture of Peruvian balsam and hot water. This was followed by poultices added with cassia pulp, camphorized fosters, bandages, a light diet, and medications to evacuate without effort.

Less than four months after Bach’s death, the operating room was installed in the Tres Cisnes restaurant (…) Three months and three weeks after the operation, Bach presented cerebral palsy of vascular origin and was unconscious. He developed a fever, possibly pneumonia, and died on the night of July 28, 1750 at the age of sixty-five, despite the best Leipzig physicians. (…)

The dear Saxon

HAMBURG, DECEMBER 5, 1704.- During the performance of the opera Cleopatra by Johann Mattheson, a nineteen-year-old German musician who leads the singers from the harpsichord. He refuses to let the composer displace him from his instruments: the dispute escalates and the two heated musicians decide to settle it in a duel. Fortunately for mankind, the sword that struck the young interpreter’s chest only broke a metal button on his coat, thus saving Handel’s life and with it the work of one of the greatest and most prolific composers remained for posterity. of music. (…)

His fame reached Italy, where he was invited by a Medici prince (…) At the age of twenty-five Handel returned for a few weeks to Germany, to Hannover. Why did he receive the appointment of “master of the chapel” of the court there, with a very high salary (fifty times higher than he had received as an organist) and permission to be absent for a year, when in reality what that court was interested in was send it to London? For some, this appointment disguised the true task assigned to the composer: to insert him into the English court and receive from him information about the state of health of Queen Anne, already very ill. The interest was that the direct successor to the throne of England was precisely the Elector of Hannover, Georg Ludwig, so the sickly Queen Anne died, Hannover needed to be aware of the events in London. (…)

His contemporaries described him as impetuous, brusque and authoritarian, but completely devoid of malice and wickedness, despite the many enemies that success produced him in London. From time to time he had uncontrolled bouts of irritability and rage. For example, on one occasion he argued with the famous French Italian singer Cuzzoni and said “Oh, ma’am! I know well that you are a true devil, but I am going to show you that I am the boss of all devils.” He then took her by the waist and led her to the window, where he threatened to throw her out into the street.

For much of his life Handel was physically healthy, endowed with a remarkable capacity for work. With a thick complexion like his father, he soon showed a frank tendency to obesity due to his irrepressible enthusiasm for food and his no less joyous fondness for alcohol, especially for Port and Madeira wines. His contemporaries called him “the Bear” for his corpulence and decomposed walk, but also for his tenacity, energy and strength. In it, several factors were combined that could well cause high blood pressure and hardening of the arteries in adulthood: being overweight, the habit of smoking tobacco (in the pipe), a sedentary life and economic and work stress.

Handel’s good health began to decline after the age of fifty, just at a time of great financial and administrative tension due to the difficulties of staging his operas; headaches, irritability, colic, rheumatic pain.

In 1737, after a period of great fatigue and disappointment, “the machine broke”: he suffered paralysis of the right arm that affected mainly the fingers of that hand, and consequently prevented him from playing the harpsichord and the organ. Along with the paralysis, he presented certain mental alterations, “which modified his understandings,” according to a written comment by a contemporary, perhaps referring to mental confusion or speech problems. (…)


Russia supplies medicine against covid-19 to Latin America without including Mexico

MEXICO CITY (apro) .- The Russian Direct Investment Fund (RDIF) and the ChemRar Group have agreed to supply 17 countries with Avifavir, Russia’s first drug approved for the treatment of covid-19. Among the nations that have the drug are 11 from Latin America, which is not included Mexico.

According to a statement posted on the RDIF website, Avifavir will be delivered to Argentina, Bulgaria, Brazil, Chile, Colombia, Ecuador, El Salvador, Honduras, Kuwait, Panama, Paraguay, Saudi Arabia, Serbia, Slovakia, South Africa, United Arab Emirates and Uruguay.

The drug has previously been delivered to Belarus, Bolivia, Kazakhstan, Kyrgyzstan, Turkmenistan and Uzbekistan, he added.

Russia approves Coronavir, the first drug against covid-19 for sale in pharmacies

Avifavir, the statement highlights, is the first drug registered in the world made based on the substance favipiravir against the coronavirus and the first in Russia approved for the treatment of covid-19.

In its statement, Russia’s sovereign wealth fund recalled that on May 29 Avifavir received a registration certificate from the Russian Ministry of Health and became the first favipiravir-based medicine in the world approved for the treatment of covid- 19.

He also highlighted that approximately five months after the Avifavir clinical trials in Russia, Fujifilm from Japan confirmed the efficacy of favipiravir against the novel coronavirus infection.

“Avifavir is now Russia’s leading anticovid drug in terms of exports. In particular, on September 21, the start of deliveries to Bolivia and other Latin American countries was announced as part of the agreement to deliver 150 thousand packages. Avifavir has also been approved by regulators in Europe, the Middle East and Asia ”, underlined the RDIF.

Russia will present its treatment against covid-19 to Latin America

“When we registered the world’s first favipiravir-based coronavirus drug, there was a lot of skepticism as people wondered how we could register it when Japan had not yet registered it,” said Kirill Dmitriev, executive director of Russia’s Direct Investment Fund.

“Now, five months after our clinical trials, we see that Japan has confirmed the clinical efficacy of favipiravir. Avifavir has been tested in more than 1,300 patients, including 408 patients in clinical trials and 940 patients during the post-registration observational clinical trial, ”he explained.

Dmitriev concluded in the release that Avifavir is also three to four times cheaper than Remdesivir, the drug approved by the United States for the treatment of Covid-19.

The price of remdesivir, a treatment for covid-19, outrages US consumers


Ryanair will open a base in Beauvais

It is the company’s fourth base in France after Marseille, Bordeaux and Toulouse.

By Le Figaro with AFP

Ryanair planes at London Stansted Airport, September 18, 2020.
Ryanair planes at London Stansted Airport, September 18, 2020. ADRIAN DENNIS / AFP

Irish airline Ryanair announced on Wednesday that it plans to open a new French base in Beauvais, in the Oise, from December, despite the novel coronavirus pandemic and the drop in traffic.

«We are delighted to announce an investment of $ 200 million for Ryanair’s fourth French base at Paris-Beauvais airport. This development will create more than 2,300 direct and indirect jobs», Assures Jason McGuinness, commercial director of Ryanair. Ryanair already has bases in Marseille, Bordeaux and Toulouse.

Jason McGuinness adds that Paris-Beauvais airport continues to offer “competitive airport charges, which is a way to increase traffic and open new lines for Ryanair’s fourth French base“. The new base will allow Ryanair to connect the Paris region to 13 European countries.

Reduction of thefts

The company “low cost»Announced last week to further reduce its flights for October, the month during which it will run at 40% of its capacity because of the impact on demand of travel restrictions decided by governments to stem the pandemic.

Travel restrictions often criticized by the boss of the group Michael O’Leary, like the quarantine required in the United Kingdom on return from several countries, and which threaten to worsen as the epidemic spreads.

Faced with this context, Ryanair announced a restructuring plan which involves the elimination of 3,000 jobs. The Ryanair group, which also includes the companies Buzz, Lauda and Malta Air, claimed 149 million passengers a year before the pandemic and some 17,000 employees.

SEE ALSO – Airbus unveils three aircraft concepts to fly on hydrogen in 2035


Dollar blue today: how much it is trading this Sunday, September 20, 2020

The official dollar closed this Sunday, September 20 at an average of $ 79.25 for sale to the public in Banco Nación, it remains without differences compared to yesterday in the stock market the dollar counted with settlement (CCL), the operation remained stable at $ 137.30%.

In the average of banks and exchange houses, the retail dollar closed today, Sunday, September 20, at $ 79.59 for sale, according to daily information provided by the Central Bank on its website.

In today’s wheel, the MEP dollar remained Stable%, at $ 129.72 per unit, while in the wholesale segment the official dollar ended at 75.38.

So, the tourist dollar or solidarity dollar With the 30% surcharge – contemplated in the Country tax – the wheel was completed in a final value of $ 103.03. While the dollar saving that includes the new 35% surcharge is priced at $ 131 pesos.

For its part, the so-called informal dollar or blue dollar today it sells on average at $ 140.00 per unit.

Fixed deadlines today

The rise in interest rates for fixed terms in banks is still in effect with a floor of 33.06% in placements by savers.

How much each bank pay today, Sunday, September 20, for fixed terms The largest banks that publish their reference value online:

Macro desk offers 33.06% for its clients

Santander River Bank offers 33.06% for its clients

Banco Galicia offers 33.06% for its clients

Bank of the Province of Buenos 33.06% for your clients

Banco BBVA Argentina SA 33.06% for your clients

Species Name Latest % Day % My % Year
BBAR ADR French Bank 2,770 -0,7 -17,8 -50,3
BMA ADR Banco Macro 15,320 -0,4 -19,2 -57,7
SUPV ADR Banco Supervielle 2,050 -2,8 -20,2 -44,3
CEPU ADR Central Puerto 2,110 -0,5 -15,9 -56,6
CAAP America Corporation 2,160 -4,0 -9,2 -64,0
CRESY ADR Cresud 2,980 1,0 -12,4 -57,7
cleave Take off 7,420 -6,3 -13,2 -45,0
EDN ADR Edenor 3,180 2,9 -2,5 -49,2
GGAL ADR Grupo Fin. Galicia 7,860 -0,3 -23,9 -51,6
IRS ADR Irsa 2,910 -2,0 -12,4 -58,0
IRCP ADR IRSA Commercial Properties 7,400 -2,6 -2,6 -2,6
LOMA Loma Negra C.I.A.S.A. 4,220 -0,7 -12,6 -46,0
MELI Free market 998,060 1,8 -14,6 74,5
PAM ADR Pampa Energía SA 10,720 0,7 -6,7 -34,8
TEO ADR Telecom Argentina 7,180 -2,3 6,2 -36,7
TS ADR Tenaris 10,910 -3,0 -6,4 -51,8
TX ADR Ternium S.A. 19,790 1,2 10,7 -10,1
TGS ADR Transportadora Gas del Sur 4,260 2,2 -9,4 -40,6
YPF ADR YPF 4,460 -2,0 -20,1 -61,5


Medicine intern commits suicide in a Yucatan clinic

TAHDZIÚ, Yuc. (apro) .- The State Secretary of Health (SSY) confirmed the suicide of a young medical intern at the Medical Unit of this town.

The victim, identified with the initials KJGK, 25 years old, was originally from Mérida, and for about a month she was assigned by the Institute of Health and Wellbeing (Insabi) to the clinic in this municipality, one of the poorest from the continent, where until yesterday he was seen working.

This morning, employees of the health center found the young woman dead, suspended from the ventilator in her office, for which they gave notice to the authorities of the Ministry of Health and the State Attorney General’s Office (FGE).

In a bulletin, the SSY regretted the fact and pointed out that, with the support of Mental Health professionals from the dependency, they carry out comprehensive actions to support family members, “who will be given the necessary help to carry out the procedures corresponding to the State Attorney General’s Office, where the rigorous legal procedure will be given.

So far the reasons for the suicide are unknown.

Note of interest: The plane raffle showcases AMLO’s talent for the show: NYT

Note of interest: Teacher accused of sexual abuse against a minor with Down syndrome linked


students launch against UADY after suicide of medical intern

MÉRIDA, Yuc. (appro). – Students from the Faculty of Medicine once again attacked the authorities of the Autonomous University of Yucatán (UADY), this time due to the recent suicide of one of their colleagues at the Tahdziú clinic, where she was doing her residency.

For reasons presumably related to her career, the young intern, KJGK, 25 years old and originally from Mérida, took her own life on September 15 in her office at the Tahdziú medical center, a municipality that by the way is among the most impoverished of the continent.

The case unleashed the anger and indignation of the students who once again filled social networks with accusations and reproaches against the authorities of the UADY and its Faculty of Medicine for the lack of interest and lack of support towards their students.

Although the girl’s death was made public on September 15, it was until the next day that the Faculty of Medicine issued a statement on the matter.

In a statement, the Faculty of Medicine expressed that it was “deeply moved by the death of the intern, KJGK, who was rendering her social service at the Tahdziú Medical Unit.”


Interns and interns from the Faculty of Medicine will return to hospitals: UADY

He assured that university authorities in coordination with personnel from the Subdirectorate of Mental Health and Education of the Ministry of Health “are already taking the pertinent actions.”

“The irreparable loss of a young doctor fills us with consternation and mourns the entire community of the Faculty,” he reiterated.

He argued that “Medicine is an arduous, hard and demanding career that demands the maximum of our abilities”, and stated: “At the Faculty we understand it that way and that is why our psychopedagogical department provides support to our students every day to prevent moments crisis ”.

Finally, he endorsed his commitment “to the comprehensive, humanistic and responsible training of students”, for which he asked heads of teaching and teachers “to maintain close communication with students and make available to those who require it, the services of the professionals who work in the psycho-pedagogical department of our dependency ”.

We recommend you: The Yucatan stadium that will meet FIFA standards: these are the details

However, such a statement stirred the anger of the students, who questioned the sayings of their authorities who, with the campaign “UADY, I do not believe you anything”, reproached a string of situations suffered by students of that maximum house of studies.

The flow of complaints from medical students includes various types of human rights violations, exploitation, excessive pressure, mistreatment, harassment.

“The department of psychopedagogy is a joke, I say it from my own skin and I know it from that of many colleagues. ‘If you can’t unsubscribe’, this has been said over and over again to students, to all those who at some point have a crisis.

Where is the humanist side? Where was the empathy? Are you moved? What if they do something about it with those doctors who only humiliate their interns? Or how about those teachers who have different colored hair or tattoos that won’t turn you down? Why don’t they do something with all the staff who are sexist and misogynistic? ”, Refuted a student.

“Don’t become a School of Medicine. Nobody puts a Civil Engineer intern to supervise ONLY the construction of a bridge. No career puts an intern to be 24 HOURS X 6 DAYS A WEEK AWAY FROM ALL SOCIAL CONTACT OTHER THAN HIS JOB “, reproached another of the nonconformists.

And he assured that the deceased doctor asked for help and “they told him to stay.”

Last April, the Faculty of Medicine came into conflict with its interns after seven of them filed a claim for protection for having been dropped from the school for refusing to return to the institutions to which they had been assigned due to the lack of security guarantees to reduce the risk of contracting covid-19.


Blue dollar today: how much it is trading this Monday, September 14, 2020

The blue dollar Today, Monday, September 14, 2020, it is trading at $ 131.00 for sale, and $ 127.00 for purchase. The gap with the official retail dollar is 65.6%

Country risk it advanced 1.4% to settle at 1,124 points, the indicator prepared by the JPMorgan Bank is shown with caution.

The dollar counted with settlement (CCL) trades today Monday at $ 126.36, while the dollar purse (MEP) operates at $ 125.17.

The official dollar Today, Monday, September 14, 2020, it is trading at $ 79 for sale, and $ 74 for purchase at Banco Nación.

Fixed deadlines today

The rise in interest rates for fixed terms in banks is still in effect with a floor of 33.06% in placements by savers.

How much each bank pay today, Monday, September 14, for fixed terms The largest banks that publish their reference value online:

Macro desk offers 33.06% for its clients

Santander River Bank offers 33.06% for its clients

Banco Galicia offers 33.06% for its clients

Bank of the Province of Buenos 33.06% for your clients

Banco BBVA Argentina SA 33.06% for your clients

Species Name Latest % Day % My % Year
BBAR ADR French Bank 3,190 -3,0 -5,3 -42,7
BMA ADR Banco Macro 17,780 -1,3 -6,2 -51,0
SUPV ADR Banco Supervielle 2,520 -0,8 -2,0 -31,5
CEPU ADR Central Puerto 2,400 0,4 -4,4 -50,6
CAAP America Corporation 2,290 2,2 -3,8 -61,8
CRESY ADR Cresud 3,080 1,3 -9,4 -56,3
cleave Take off 7,740 0,9 -9,5 -42,6
EDN ADR Edenor 3,450 -0,9 5,8 -44,9
GGAL ADR Grupo Fin. Galicia 9,400 -3,4 -9,0 -42,1
IRS ADR Irsa 3,050 0,3 -8,1 -55,9
IRCP ADR IRSA Commercial Properties 8,050 0 0 0
LOMA Loma Negra C.I.A.S.A. 5,120 2,8 6,0 -34,5
MELI Free market 1.054 2,1 -9,8 84,4
PAM ADR Pampa Energía SA 11,760 -0,5 2,4 -28,4
TEO ADR Telecom Argentina 7,420 7,5 9,8 -34,6
TS ADR Tenaris 10,640 -0,8 -8,8 -53,0
TX ADR Ternium S.A. 18,630 1,9 4,2 -15,3
TGS ADR Transportadora Gas del Sur 4,650 -0,9 -1,1 -35,2
YPF ADR YPF 5,100 -1,2 -8,6 -56,0


Rheumatoid arthritis drug could help treat covid-19

MEXICO CITY (apro) .- The pharmaceutical company Eli Lilly announced that the combination of its rheumatoid arthritis treatment baricitinib with remdesivir reduced the recovery time in hospitalized patients with covid-19.

Eli Lilly explained that during the Covid-19 Adaptive Treatment Trial (ACTT-2), researchers observed a reduction of approximately one day in the mean recovery time of patients treated with baricitinib combined with the substance remdesivir, compared to those who were only treated with remdesivir, therefore they rated the finding as statistically significant.

White House epidemiologist predicts that the US will return to normal by the end of 2021

The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institute of Health (NIH), included more than 1,000 patients and began on May 8 to evaluate the efficacy and safety of a dose. of 4 mg baricitinib plus remdesivir versus remdesivir in hospitalized patients with COVID-19.

According to Eli Lilly, the combination met the primary endpoint of reduced recovery time, which was defined as that the participant was well enough for hospital discharge, meaning that they no longer needed supplemental oxygen or care continued in the hospital, or was no longer hospitalized on the 29th.

A German vaccine against covid-19 will be tested in Nuevo León

Eli Lilly reported that additional analysis is underway to understand other clinical outcome data, including mortality and safety data, and that NIAID is expected to publish full study details in a peer-reviewed journal.

Eli Lilly also indicated that he plans to discuss the emergency use authorization of the combination with the US Food and Drug Administration (FDA) and explore similar measures with other regulatory agencies for baricitinib as a treatment. of hospitalized patients with covid-19. If authorized, the company will propose make baricitinib available through commercial channels and will work with hospitals and governments to ensure patient access.

The WHO urges not to greet elbow by covid-19 and proposes another alternative


Lego doped by the Covid-19 pandemic

Thanks to the internet, the Danish manufacturer of plastic bricks has gained market share.

Lego has benefited from a boom in demand
Lego has benefited from a boom in demand LEGO

Always stronger. Lego, which had experienced a slump three years ago, is regaining insolent health. Pushing half the planet to confine itself, the Covid-19 pandemic boosted the sales of the king of plastic bricks in the first half of the year, and reinforced his model. The Danish manufacturer, neck-and-neck with Hasbro behind world toy leader Mattel, is gaining customers and market share.

Between January and the end of June, turnover increased by 7% to 15.7 billion Danish kroner (2.1 billion euros). The net profit resists (-1%), to 2.6 billion crowns (354 million euros). “We have reaped the benefits of our long-term investments in e-commerce and innovation, welcomes the CEO, Niels B. Christiansen, called in disaster after the removal of more than 10% of the workforce in 2017. Our strong portfolio has appealed to builders of all ages. Our newly updated e-commerce platform and chain

This article is for subscribers only. You have 72% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time